{"computation_calculations":"<a href='https://icane.github.io/ods-cantabria/assets/pdf/3.b.1.1.pdf' target='_blank'>Cobertura de vacunaci\u00f3n de recuerdo contra difteria, t\u00e9tanos y tosferina en la poblaci\u00f3n infantil</a><br><a href='https://icane.github.io/ods-cantabria/assets/pdf/3.b.1.3.pdf' target='_blank'>Cobertura de vacunaci\u00f3n de recuerdo contra neumococo en la poblaci\u00f3n infantil</a><br><a href='https://icane.github.io/ods-cantabria/assets/pdf/3.b.1.4.pdf' target='_blank'>Cobertura de vacunaci\u00f3n de segunda dosis contra sarampi\u00f3n, rubeola y parotiditis en la poblaci\u00f3n infantil</a><br><a href='https://icane.github.io/ods-cantabria/assets/pdf/3.b.1.5.pdf' target='_blank'>Cobertura de vacunaci\u00f3n de segunda dosis contra papiloma humano en las adolescentes</a>","data_non_statistical":false,"indicator_name":"Proportion of the target population covered by all vaccines included in their national programme","indicator_number":"3.b.1","reporting_status":"complete","graph_title":"Proportion of the target population covered by all vaccines included in their national programme","graph_type":"line","national_geographical_coverage":"Cantabria y Espa\u00f1a","published":true,"sdg_goal":"3","target_name":"Support the research and development of vaccines and medicines for the communicable and non\u2010communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","target_id":"3.b","page_content":"","es":{"computation_calculations":"<a href='https://icane.github.io/ods-cantabria/assets/pdf/3.b.1.1.pdf' target='_blank'>Cobertura de vacunaci\u00f3n de recuerdo contra difteria, t\u00e9tanos y tosferina en la poblaci\u00f3n infantil</a><br><a href='https://icane.github.io/ods-cantabria/assets/pdf/3.b.1.3.pdf' target='_blank'>Cobertura de vacunaci\u00f3n de recuerdo contra neumococo en la poblaci\u00f3n infantil</a><br><a href='https://icane.github.io/ods-cantabria/assets/pdf/3.b.1.4.pdf' target='_blank'>Cobertura de vacunaci\u00f3n de segunda dosis contra sarampi\u00f3n, rubeola y parotiditis en la poblaci\u00f3n infantil</a><br><a href='https://icane.github.io/ods-cantabria/assets/pdf/3.b.1.5.pdf' target='_blank'>Cobertura de vacunaci\u00f3n de segunda dosis contra papiloma humano en las adolescentes</a>","data_non_statistical":false,"indicator_name":"Proportion of the target population covered by all vaccines included in their national programme","indicator_number":"3.b.1","reporting_status":"complete","graph_title":"Proportion of the target population covered by all vaccines included in their national programme","graph_type":"line","national_geographical_coverage":"Cantabria y Espa\u00f1a","published":true,"sdg_goal":"3","target_name":"Support the research and development of vaccines and medicines for the communicable and non\u2010communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","target_id":"3.b","page_content":""},"national_metadata_updated_date":"2025-01-30","national_data_updated_date":"2025-10-28","target_number":"3.b","goal_number":"3","indicator_sort_order":"03-0b-01"}